NCT01372696 (C-LST) is a NA clinical trial of Sample of polyp in Colonic Polyp, sponsored by Professor Michael Bourke.

Who is sponsoring NCT01372696?

NCT01372696 is sponsored by Professor Michael Bourke.

What drugs are being tested in NCT01372696?

Interventions in NCT01372696: Sample of polyp.

What condition does NCT01372696 study?

NCT01372696 studies Colonic Polyp, Colon Cancer.

Is NCT01372696 still recruiting?

NCT01372696 is currently withdrawn. Last updated 27 March 2025.

Last reviewed 2025-03-27 · How we verify

NCT01372696: C-LST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endoscopic Characteristics of Colonic Tumours

Withdrawn NA Last updated 27 March 2025

What this trial tests

NA trial testing Sample of polyp in Colonic Polyp. Withdrawn.

Timeline

3 June 2019

Primary endpoint
3 June 2019

3 June 2019

Quick facts

Lead sponsor	Professor Michael Bourke
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Start date	3 June 2019
Primary completion	3 June 2019
Estimated completion	3 June 2019
Sites	1 location across Australia

Drugs / interventions tested

Sample of polyp

Conditions studied

Colonic Polyp — all drugs for Colonic Polyp →
Colon Cancer — all drugs for Colon Cancer →

Sponsor

Professor Michael Bourke

Who can join

18 and older, any sex, with Colonic Polyp or Colon Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose is to investigate whether polyps that look different at colonoscopy, have formed via different mutations and have different risks of turning into cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Colonic Polyp

Currently open trials in the same condition.

NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
NCT07456111 — A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy · Phase 4 · recruiting
NCT06483503 — Extra Wide Field of View Lens Study · active not recruiting
NCT06077435 — Comparative Analysis of AI Software for Enhanced Polyp Detection and Diagnosis · NA · recruiting

Other Professor Michael Bourke trials

Trials by the same sponsor.

NCT01369316 — Circumferential Submucosal Incision Endoscopic Mucosal Resection Versus Conventional Endoscopic Mucosal Resection of Col · NA · withdrawn
NCT02004782 — Barretts oEsophageal Resection With Steroid Therapy Trial · Phase 4 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01372696 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Professor Michael Bourke
Last refreshed: 27 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01372696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing